Clinical Trials · NCT02981069
Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Enrollment
- 90
- Start date
- Dec 2017
- Locations
- 1 site, United States
- Primary endpoint
- Change in Endogenous Glucose Production (EGP) After Acute Exposure to a Single Dose and Again After 16 Weeks of Treatment